Matinas BioPharma Logo
US5768104029
A42MK1

Matinas BioPharma

Loading quotes...

Forecast

Buy
  7
Hold
  1
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Matinas BioPharma had revenue of €0 and net profit of -€1.16m
(EUR) June 2026
YoY
Revenue 0 -
Gross profit -3.5k 96.67%
Net profit -1.16m 73.89%
EBITDA -1.56m 64.10%

Fundamentals

Metric Value
Market capitalization
€360.75k
Number of shares
427.08k
52-week high/low
€16.95 - €0.74
Dividends No
Beta
1.70
P/E ratio
-0.05
PEG ratio
0.00
P/B ratio
0.22
P/S ratio
0.00

Company profile

Name
Matinas BioPharma
CEO
Jerome D. Jabbour
Employees 2
🍪

Parqet  uses cookies. Learn more